阿糖胞苷或柔红霉素与全反式维A酸的不同联用方式致体外HL-60凋亡差异

张春; 陆晓彤; 陈敏玲; 张顺国; 王燕琼; 赵薇; 张健

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

阿糖胞苷或柔红霉素与全反式维A酸的不同联用方式致体外HL-60凋亡差异

张春, 陆晓彤, 陈敏玲, 张顺国, 王燕琼, 赵薇, 张健

文章导航 > 药学实践与服务 > 2010 > 28(4): 262-264,273

张春, 陆晓彤, 陈敏玲, 张顺国, 王燕琼, 赵薇, 张健. 阿糖胞苷或柔红霉素与全反式维A酸的不同联用方式致体外HL-60凋亡差异[J]. 药学实践与服务, 2010, 28(4): 262-264,273.

引用本文:

ZHANG Chun, LU Xiao-tong, CHEN Min-ling, ZHANG Shun-guo, WANG Yan-qiong, ZHAO Wei, ZHANG Jian. Different administrations of combination cytarabine or daunorubicin with all-trans retinoic acid lead to variance of HL-60''s apoptosis and respectively mechanism in vitro[J]. Journal of Pharmaceutical Practice and Service, 2010, 28(4): 262-264,273.

Citation:

ZHANG Chun, LU Xiao-tong, CHEN Min-ling, ZHANG Shun-guo, WANG Yan-qiong, ZHAO Wei, ZHANG Jian. Different administrations of combination cytarabine or daunorubicin with all-trans retinoic acid lead to variance of HL-60''s apoptosis and respectively mechanism in vitro[J]. Journal of Pharmaceutical Practice and Service, 2010, 28(4): 262-264,273.

阿糖胞苷或柔红霉素与全反式维A酸的不同联用方式致体外HL-60凋亡差异

1.
上海交通大学医学院附属新华医院,上海200092
2.
上海交通大学医学院附属上海儿童医学中心,上海200127

Different administrations of combination cytarabine or daunorubicin with all-trans retinoic acid lead to variance of HL-60''s apoptosis and respectively mechanism in vitro

1.
Xinhua Hospital offiliated to Shanghai Jiaotong University Medical School,Shanghai 200092,Chain
2.
Department of Pharmacy,Shanghai Children's Medical Center affiliated to Shanghai Jiaotong University Medical School,Shanghai 200127,China

摘要: 目的: 研究阿糖胞苷(cytarabine,Ara-C)或柔红霉素(daunorubicine,DNR)与全反式维A酸(all-trans retinoicacid,ATRA)以不同方式联用,体外作用于白血病细胞株HL-60,导致细胞凋亡差异及可能机制。 方法: 体外培养HL-60细胞株,细胞悬液以浓度2.0×10⁵/ml接种后分7组,分别为A:对照组;B:Ara-C与ATRA同时联用48 h组,Ara-C+ATRA48 h;C:ATRA与Ara-C先后联用48 h组,ATRA 24 h→Ara-C 24 h;D:Ara-C与ATRA先后联用48 h组,Ara-C 24 h→ATRA 24 h;E:DNR与ATRA同时联用48 h组,DNR+ATRA48 h;F:ATRA与DNR先后联用48 h组,ATRA24 h→DNR24 h;G:DNR与AT-RA先后联用48 h组,DNR 24 h→ATRA24 h。Ara-C、DNR、ATRA给药浓度均为1.0×10^-7mol/L。应用流式细胞仪、Westernblotting观察药物不同方式联用致HL-60细胞凋亡的差异及相关机制变化。 结果: 与A组相比,D组HL-60细胞凋亡比例轻度增加(50±14.7)%,抗凋亡蛋白Bcl-2消失;E组和G组HL-60凋亡细胞明显增多,其中E组能最大限度减少HL-60存活数量,使HL-60细胞死亡数目增加,达(4.00±0.56)%;E、F、G组抗凋亡蛋白Bcl-2均消失。 结论: 同时联用DNR与ATRA能显著减少HL-60细胞存活率,两药的三种联用方式均可使抗凋亡蛋白Bcl-2消失。但是,首先应用小剂量Ara-C,随后应用AT-RA的联用方式可明显增多细胞凋亡数目,抑制HL-60细胞的抗凋亡蛋白Bcl-2不能表达,有效控制细胞凋亡方向,是最有潜力的药物联用方式。
- 阿糖胞苷 /
- 柔红霉素 /
- 全反式维A酸 /
- HL-60 /
- 联用 /
- 凋亡 /
- 抗凋亡蛋白
Abstract: Objective To investigate variance of apoptosis and correspondingly mechanism in HL-60 cell line in vitro by different combinations adminstration of three drug including cytarabine,daunorubicin and all-trans retinoic acid.Methonds HL-60 cell line was cultured in vitro,cell suspension was divided into different 7 groups which's density was 2.0×10⁵/ml : Group A: control;Group B:Ara-C and ATRA were simultaneous applied in cells for 48 h(Ara-C+ATRA 48 h);Group C: ATRA and Ara-C subsequently administrated respectively for 24 h that is ATRA was applied first for 24 h,then followed by Ara-C for 24 h.Group D: Ara-C and ATRA subsequently administrated respectively for 24 h that is Ara-C was applied first for 24 h,then followed by ATRA for 24 h;Group E: DNR and ATRA simultaneously administrated for 48 h;Group F: DNR and ATRA subsequently administrated respectively for 24 h that is DNR was applied first for 24 h,then followed by ATRA for 24 h.Group G: ATRA and DNR subsequently administrated respectively for 24 h that is ATRA was applied first for 24 h,then followed by DNR for 24 h.All drug concentrations of Ara-C,DNR and ATRA were 1.0×10^-7 mol/L.The ratio of apoptosis cells was evaluated by flow cytometry.Anti-apoptosis protein Bcl-2 was checked by Western Blotting. Results The ratio of cell apoptosis in D group increase slightly,the rate of increase in apoptosis was(50±14.7) %,its protein Bcl-2 disappeared.Compared with control group,both two groups including E and G groups caused the apoptosis ratio significant higher.The alive cells' ratio in E group was reduced to the highest degree and the amount of dead cells increased to a degree of(4.00±0.56) %.Anti-apoptosis protein Bcl-2 in E,F,G groups all disappeared. Conclusion Combination DNR and ATRA simultaneously can effectively decrease HL-60 survival.Three ways of combination DNR with ATRA can signifi- cantly cause protein Bcl-2 disappear.But low dose of Ara-C was administrated first then followed by ATRA can not only increase slightly the ratio of apoptosis of HL-60 cell,but also inhibited anti-apoptosis protein Bcl-2 to express and effectively controled the way of HL-60 cell's death to apoptosis,and we concluded that this combination is the most potentiall way.
- cytarabine /
- daunorubicin /
- all-trans retinoic acid /
- HL-60 /
- combination /
- apoptosis /
- anti-apoptosis protein

[1]	杜江源, 张兰林, 蔡同凯, 曹永兵. 毒胡萝卜素联合吉非替尼改善人肺腺癌细胞PC9/GR的耐药性研究 . 药学实践与服务, 2024, 42(3): 121-126. doi: 10.12206/j.issn.2097-2024.202209018
[2]	竺东杰, 贺新征, 邹杰, 余史丹, 李红霞. 雷公藤甲素对大鼠脑缺血再灌注损伤的影响及机制研究 . 药学实践与服务, 2024, 42(): 1-6. doi: 10.12206/j.issn.2097-2024.202311021
[3]	孟盼盼, 宋慕格, 杨世超, 陈克明, 杨中铎, 马慧萍. 基于Keap1/Nrf2/HO-1信号通路研究利舒康胶囊对高原缺氧小鼠学习记忆障碍的改善作用 . 药学实践与服务, 2023, 41(): 1-7. doi: 10.12206/j.issn.2097-2024.202303006
[4]	石志群, 高迎春, 张冬梅, 陈克明, 景临林, 马慧萍. 7-羟乙基白杨素对高原脑水肿的作用机制初探 . 药学实践与服务, 2022, 40(5): 399-402, 415. doi: 10.12206/j.issn.2097-2024.202205090
[5]	崔晓林, 桂玲, 朱茜, 陆峰. 表面增强拉曼光谱与其他检测技术联用的概述 . 药学实践与服务, 2022, 40(3): 202-207, 253. doi: 10.12206/j.issn.1006-0111.202110091
[6]	张城, 马剑平, 沈育桦, 朱文君, 刘河龙, 邱彦. 活性多肽GRGDS对氧糖剥夺诱导PC12细胞损伤的保护作用及其机制研究 . 药学实践与服务, 2021, 39(4): 317-321, 330. doi: 10.12206/j.issn.1006-0111.202007053
[7]	王玮婷, 殷雪琴, 夏金娥, 张夏炎. 五味子乙素通过ROS介导内质网应激诱导人乳腺癌MDA-MB-231细胞凋亡的研究 . 药学实践与服务, 2021, 39(6): 499-503, 533. doi: 10.12206/j.issn.1006-0111.202106123
[8]	陈雪, 黄泽豪, 郑承剑. 敲减MCCC2对前列腺癌细胞系DU145增殖、迁移和凋亡的影响 . 药学实践与服务, 2021, 39(3): 215-220. doi: 10.12206/j.issn.1006-0111.202104020
[9]	唐杰, 林厚文, 孙凡. 海绵来源的smenospongine诱导乳腺癌MCF7细胞凋亡机制研究 . 药学实践与服务, 2018, 36(5): 399-402,421. doi: 10.3969/j.issn.1006-0111.2018.05.004
[10]	王筱婧, 王东兴, 范洁, 高越, 张海. 泽漆抑制三阴乳腺癌MDA-MB-231细胞及其凋亡机制研究 . 药学实践与服务, 2017, 35(4): 337-340,358. doi: 10.3969/j.issn.1006-0111.2017.04.012
[11]	张海容. 术前复方苦参注射液联合化疗对肺癌患者恶性程度的影响 . 药学实践与服务, 2016, 34(4): 359-362. doi: 10.3969/j.issn.1006-0111.2016.04.020
[12]	姜舒, 芮耀诚, 李铁军. 心肌梗死中涉及炎症和凋亡的机制 . 药学实践与服务, 2016, 34(2): 119-123. doi: 10.3969/j.issn.1006-0111.2016.02.007
[13]	杨宏, 倪敏, 赵心彬, 陶霞. 辐射致组织损伤凋亡机制的研究概况 . 药学实践与服务, 2014, 32(2): 96-97,149. doi: 10.3969/j.issn.1006-0111.2014.02.005
[14]	邓晶晶, 纪圣君, 陈烨, 林晓琳, 王蕊, 徐利锋. 应用中空纤维测定法评价藤甲酰苷对人癌细胞生长的抑制作用 . 药学实践与服务, 2014, 32(4): 266-269. doi: 10.3969/j.issn.1006-0111.2014.04.007
[15]	涂传发, 王丽君, 金都, 杨宏伟, 张幽幽, 牟晓月. 阿魏酸哌嗪与贝那普利联用对早期糖尿病肾病患者尿白蛋白排泄率的影响 . 药学实践与服务, 2013, 31(1): 49-50,56. doi: 10.3969/j.issn.1006-0111.2013.01.014
[16]	李英华, 胡振林, 张俊平. 核糖体蛋白S3a在肿瘤细胞增殖分化和凋亡调控作用的研究概况 . 药学实践与服务, 2012, 30(3): 165-167,225. doi: 10.3969/j.issn.1006-0111.2012.03.003
[17]	周恒, 林焕冰, 卓烨烨, 毕炳添, 李国熊, 徐江平. 葡萄籽原花青素对血管性痴呆大鼠空间学习记忆能力的影响 . 药学实践与服务, 2011, 29(3): 208-211.
[18]	叶齐, 王婧, 郭学青, 陈崇宏, 张俊平. 依托泊苷通过蛋白酶体通路诱导白血病细胞凋亡 . 药学实践与服务, 2010, 28(1): 25-28,69.
[19]	耿礼文, 薄挽澜, 梁桃. 砷剂对人胃癌细胞凋亡及LRP耐药基因表达影响的研究 . 药学实践与服务, 2009, 27(2): 129-131.
[20]	管孝鞠, 王治乔, 王爱平. 定量检测细胞凋亡的ELISA法 . 药学实践与服务, 2000, (1): 39-42.

点击查看大图

计量

文章访问数: 1856
HTML全文浏览量: 188
PDF下载量: 582
被引次数: 0

阿糖胞苷或柔红霉素与全反式维A酸的不同联用方式致体外HL-60凋亡差异

1. 上海交通大学医学院附属新华医院,上海200092

2. 上海交通大学医学院附属上海儿童医学中心,上海200127

收稿日期: 2009-12-11
修回日期: 2010-01-11

关键词:

阿糖胞苷 /

柔红霉素 /

全反式维A酸 /

HL-60 /

联用 /

凋亡 /

抗凋亡蛋白

摘要: 目的: 研究阿糖胞苷(cytarabine,Ara-C)或柔红霉素(daunorubicine,DNR)与全反式维A酸(all-trans retinoicacid,ATRA)以不同方式联用,体外作用于白血病细胞株HL-60,导致细胞凋亡差异及可能机制。 方法: 体外培养HL-60细胞株,细胞悬液以浓度2.0×10⁵/ml接种后分7组,分别为A:对照组;B:Ara-C与ATRA同时联用48 h组,Ara-C+ATRA48 h;C:ATRA与Ara-C先后联用48 h组,ATRA 24 h→Ara-C 24 h;D:Ara-C与ATRA先后联用48 h组,Ara-C 24 h→ATRA 24 h;E:DNR与ATRA同时联用48 h组,DNR+ATRA48 h;F:ATRA与DNR先后联用48 h组,ATRA24 h→DNR24 h;G:DNR与AT-RA先后联用48 h组,DNR 24 h→ATRA24 h。Ara-C、DNR、ATRA给药浓度均为1.0×10^-7mol/L。应用流式细胞仪、Westernblotting观察药物不同方式联用致HL-60细胞凋亡的差异及相关机制变化。 结果: 与A组相比,D组HL-60细胞凋亡比例轻度增加(50±14.7)%,抗凋亡蛋白Bcl-2消失;E组和G组HL-60凋亡细胞明显增多,其中E组能最大限度减少HL-60存活数量,使HL-60细胞死亡数目增加,达(4.00±0.56)%;E、F、G组抗凋亡蛋白Bcl-2均消失。 结论: 同时联用DNR与ATRA能显著减少HL-60细胞存活率,两药的三种联用方式均可使抗凋亡蛋白Bcl-2消失。但是,首先应用小剂量Ara-C,随后应用AT-RA的联用方式可明显增多细胞凋亡数目,抑制HL-60细胞的抗凋亡蛋白Bcl-2不能表达,有效控制细胞凋亡方向,是最有潜力的药物联用方式。

English Abstract

Different administrations of combination cytarabine or daunorubicin with all-trans retinoic acid lead to variance of HL-60''s apoptosis and respectively mechanism in vitro

1. Xinhua Hospital offiliated to Shanghai Jiaotong University Medical School,Shanghai 200092,Chain

2. Department of Pharmacy,Shanghai Children's Medical Center affiliated to Shanghai Jiaotong University Medical School,Shanghai 200127,China

Received Date: 2009-12-11
Rev Recd Date: 2010-01-11

Keywords:

Abstract: Objective To investigate variance of apoptosis and correspondingly mechanism in HL-60 cell line in vitro by different combinations adminstration of three drug including cytarabine,daunorubicin and all-trans retinoic acid.Methonds HL-60 cell line was cultured in vitro,cell suspension was divided into different 7 groups which's density was 2.0×10⁵/ml : Group A: control;Group B:Ara-C and ATRA were simultaneous applied in cells for 48 h(Ara-C+ATRA 48 h);Group C: ATRA and Ara-C subsequently administrated respectively for 24 h that is ATRA was applied first for 24 h,then followed by Ara-C for 24 h.Group D: Ara-C and ATRA subsequently administrated respectively for 24 h that is Ara-C was applied first for 24 h,then followed by ATRA for 24 h;Group E: DNR and ATRA simultaneously administrated for 48 h;Group F: DNR and ATRA subsequently administrated respectively for 24 h that is DNR was applied first for 24 h,then followed by ATRA for 24 h.Group G: ATRA and DNR subsequently administrated respectively for 24 h that is ATRA was applied first for 24 h,then followed by DNR for 24 h.All drug concentrations of Ara-C,DNR and ATRA were 1.0×10^-7 mol/L.The ratio of apoptosis cells was evaluated by flow cytometry.Anti-apoptosis protein Bcl-2 was checked by Western Blotting. Results The ratio of cell apoptosis in D group increase slightly,the rate of increase in apoptosis was(50±14.7) %,its protein Bcl-2 disappeared.Compared with control group,both two groups including E and G groups caused the apoptosis ratio significant higher.The alive cells' ratio in E group was reduced to the highest degree and the amount of dead cells increased to a degree of(4.00±0.56) %.Anti-apoptosis protein Bcl-2 in E,F,G groups all disappeared. Conclusion Combination DNR and ATRA simultaneously can effectively decrease HL-60 survival.Three ways of combination DNR with ATRA can signifi- cantly cause protein Bcl-2 disappear.But low dose of Ara-C was administrated first then followed by ATRA can not only increase slightly the ratio of apoptosis of HL-60 cell,but also inhibited anti-apoptosis protein Bcl-2 to express and effectively controled the way of HL-60 cell's death to apoptosis,and we concluded that this combination is the most potentiall way.

引用本文:

Citation:

ZHANG Chun, LU Xiao-tong, CHEN Min-ling, ZHANG Shun-guo, WANG Yan-qiong, ZHAO Wei, ZHANG Jian. Different administrations of combination cytarabine or daunorubicin with all-trans retinoic acid lead to variance of HL-60''s apoptosis and respectively mechanism in vitro[J]. Journal of Pharmaceutical Practice and Service, 2010, 28(4): 262-264,273.

全文HTML

下载: 全尺寸图片幻灯片

返回文章

用微信扫码二维码

分享至好友和朋友圈

主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

电话: （021）81871324,81871397 E-mail: yxsjzzs@163.com

网站备案号沪ICP备05003363号-1

本系统由北京仁和汇智信息技术有限公司开发

留言板

阿糖胞苷或柔红霉素与全反式维A酸的不同联用方式致体外HL-60凋亡差异

Different administrations of combination cytarabine or daunorubicin with all-trans retinoic acid lead to variance of HL-60''s apoptosis and respectively mechanism in vitro

计量

出版历程

阿糖胞苷或柔红霉素与全反式维A酸的不同联用方式致体外HL-60凋亡差异

1. 上海交通大学医学院附属新华医院,上海200092 2. 上海交通大学医学院附属上海儿童医学中心,上海200127

English Abstract

Different administrations of combination cytarabine or daunorubicin with all-trans retinoic acid lead to variance of HL-60''s apoptosis and respectively mechanism in vitro

1. Xinhua Hospital offiliated to Shanghai Jiaotong University Medical School,Shanghai 200092,Chain 2. Department of Pharmacy,Shanghai Children's Medical Center affiliated to Shanghai Jiaotong University Medical School,Shanghai 200127,China

全文HTML

目录

1. 上海交通大学医学院附属新华医院,上海200092

2. 上海交通大学医学院附属上海儿童医学中心,上海200127

1. Xinhua Hospital offiliated to Shanghai Jiaotong University Medical School,Shanghai 200092,Chain

2. Department of Pharmacy,Shanghai Children's Medical Center affiliated to Shanghai Jiaotong University Medical School,Shanghai 200127,China